Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 21 12:57PM ET
12.94
Dollar change
-0.12
Percentage change
-0.96
%
Index- P/E- EPS (ttm)-0.50 Insider Own0.01% Shs Outstand1.12B Perf Week0.19%
Market Cap14.51B Forward P/E4.91 EPS next Y2.64 Insider Trans-71.38% Shs Float1.12B Perf Month12.66%
Income-559.00M PEG- EPS next Q0.52 Inst Own52.31% Short Float1.63% Perf Quarter43.04%
Sales15.84B P/S0.92 EPS this Y-6.16% Inst Trans9.12% Short Ratio1.76 Perf Half Y34.70%
Book/sh6.70 P/B1.93 EPS next Y9.78% ROA-1.28% Short Interest18.32M Perf Year28.68%
Cash/sh2.88 P/C4.50 EPS next 5Y1.60% ROE-7.27% 52W Range7.09 - 13.35 Perf YTD23.99%
Dividend Est.- P/FCF6.26 EPS past 5Y26.63% ROI-2.15% 52W High-3.03% Beta1.04
Dividend TTM- Quick Ratio0.69 Sales past 5Y-2.69% Gross Margin48.23% 52W Low82.71% ATR (14)0.37
Dividend Ex-DateNov 27, 2017 Current Ratio1.02 EPS Y/Y TTM76.40% Oper. Margin20.12% RSI (14)66.53 Volatility2.16% 2.93%
Employees37851 Debt/Eq2.70 Sales Y/Y TTM6.09% Profit Margin-3.53% Recom2.08 Target Price14.88
Option/ShortYes / Yes LT Debt/Eq2.46 EPS Q/Q134.82% Payout- Rel Volume0.86 Prev Close13.07
Sales Surprise10.69% EPS Surprise30.29% Sales Q/Q13.52% EarningsJan 31 BMO Avg Volume10.41M Price12.94
SMA204.71% SMA5014.10% SMA20037.11% Trades Volume4,947,204 Change-0.96%
Date Action Analyst Rating Change Price Target Change
Feb-12-24Upgrade Piper Sandler Neutral → Overweight $12 → $19
Jan-23-24Upgrade Jefferies Hold → Buy $10 → $14
Jan-03-24Upgrade Piper Sandler Underweight → Neutral $8 → $12
Dec-18-23Initiated HSBC Securities Buy $13
Nov-27-23Upgrade UBS Neutral → Buy $11 → $13
Jul-06-23Upgrade UBS Sell → Neutral $7 → $8
May-25-23Initiated Morgan Stanley Equal-Weight $10
May-18-23Upgrade Evercore ISI In-line → Outperform
Jan-19-23Downgrade Jefferies Buy → Hold $10 → $12
Nov-14-22Downgrade JP Morgan Neutral → Underweight $11 → $10
Feb-20-24 08:30AM
04:43AM
04:00AM
Feb-16-24 09:04AM
08:57AM
12:08AM Loading…
Feb-13-24 12:08AM
Feb-12-24 10:18AM
Feb-09-24 05:02PM
Feb-05-24 09:02AM
Feb-01-24 11:42AM
Jan-31-24 04:05PM
03:51PM
02:55PM
01:30PM
01:07PM
10:30AM Loading…
10:30AM
10:20AM
09:09AM
08:10AM
07:52AM
07:20AM
07:00AM
06:32AM
06:20AM
06:00AM
Jan-28-24 12:42PM
Jan-26-24 09:15AM
Jan-25-24 09:40AM
Jan-23-24 01:43AM
Jan-12-24 09:00AM
05:21AM Loading…
Jan-10-24 05:21AM
Jan-02-24 04:30PM
Dec-29-23 06:43PM
06:34PM
06:14PM
Dec-28-23 04:30PM
Dec-26-23 10:51AM
Dec-22-23 10:54AM
Dec-21-23 05:45AM
Dec-15-23 05:21AM
Dec-14-23 08:30AM
Dec-07-23 02:03PM
Dec-06-23 02:00AM
Nov-30-23 08:30AM
Nov-27-23 10:14AM
09:56AM
09:37AM
08:15AM
01:50AM
Nov-24-23 08:16PM
Nov-20-23 04:30PM
Nov-17-23 08:30AM
Nov-15-23 07:03PM
Nov-13-23 08:10AM
08:00AM
Nov-12-23 12:02AM
Nov-09-23 01:21PM
Nov-08-23 04:31PM
04:01PM
03:05PM
02:15PM
01:22PM
12:05PM
09:30AM
09:01AM
08:04AM
07:40AM
07:37AM
07:27AM
07:00AM
Nov-07-23 04:30PM
Nov-02-23 11:23AM
08:00AM
Nov-01-23 07:31PM
Oct-30-23 04:35PM
Oct-25-23 09:00AM
Oct-18-23 04:56AM
Oct-17-23 01:30AM
Oct-10-23 12:26PM
10:52AM
Oct-06-23 05:11PM
04:30PM
Oct-04-23 07:45PM
04:08PM
10:47AM
10:37AM
01:07AM
Sep-28-23 04:05PM
Sep-26-23 04:33PM
Sep-20-23 07:34PM
Sep-13-23 05:21AM
Sep-06-23 04:30PM
08:00AM
Sep-01-23 12:04AM
Aug-31-23 11:02AM
Aug-23-23 03:49AM
Aug-22-23 01:22PM
09:19AM
Aug-21-23 07:27PM
06:48PM
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Drape EricExecutive VP Global OperationsFeb 16Sale13.05173,2612,261,9051Feb 21 07:37 AM
Francis Richard DPresident and CEOFeb 15Sale13.1574,530980,17487,125Feb 20 07:42 AM
Weiss AmirChief Accounting OfficerFeb 01Sale12.3731,766392,95510,676Feb 05 07:49 AM
Kalif Eliyahu SharonEVP, Chief Financial OfficerAug 07Sale9.7335,125341,88999,162Aug 09 04:02 PM
Weiss AmirChief Accounting OfficerAug 04Sale9.921,98119,65842,442Aug 07 04:15 PM
Hughes Eric ASee "Remarks"Aug 01Sale8.3052,742437,6900Aug 03 07:09 AM
Dethlefs SvenEVP, North America CommercialMar 07Sale9.4358,066547,440165,381Mar 08 04:03 PM
Daniell RichardExec. VP, European CommercialMar 07Sale9.4354,007509,17369,770Mar 08 04:02 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 07Sale9.4349,475466,4452,974Mar 08 04:05 PM
Drape EricExecutive VP Global OperationsMar 07Sale9.434,69944,302173,262Mar 08 04:04 PM
Dethlefs SvenEVP, North America CommercialMar 06Sale9.9319,355192,213223,447Mar 08 04:03 PM
Daniell RichardExec. VP, European CommercialMar 06Sale9.9318,002178,776123,777Mar 08 04:02 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 06Sale9.9316,491163,77052,449Mar 08 04:05 PM
Drape EricExecutive VP Global OperationsMar 06Sale9.931,56615,552177,961Mar 08 04:04 PM
Stark David MatthewExec. VP Chief Legal OfficerFeb 28Sale9.8963,383626,6422,974Mar 02 07:38 AM
Dethlefs SvenEVP, North America CommercialFeb 28Sale9.8959,655589,785165,381Mar 02 07:33 AM
Daniell RichardExec. VP, European CommercialFeb 28Sale9.8944,252437,50243,182Mar 02 07:33 AM
Drape EricExecutive VP Global OperationsFeb 28Sale9.8933,685333,03087,789Mar 02 07:34 AM